Prognostic Role of Circular RNAs in Mantle Cell Lymphoma: A Competing Endogenous RNA Network Analysis [0.03%]
circRNA的预后作用及ceRNA网络在套细胞淋巴瘤中的作用分析
Chen-Xuan Huang,Xu-Dong Ma,Zhi-Yong Huang et al.
Chen-Xuan Huang et al.
Objective: This study evaluated the prognostic role of circular RNAs (circRNAs) in individuals diagnosed with mantle cell lymphoma (MCL), using the framework of the competing endogenous RNA (ceRNA) network model. ...
José Manuel Moreno-Mirón,Guillermo José Ruiz-Argüelles,Moisés Manuel Gallardo-Pérez et al.
José Manuel Moreno-Mirón et al.
The gastro-intestinal (GI; gut) microbiota is important in the development and function of haematopoiesis. Abnormalities of the gut microbiota are termed dysbiosis which is associated with the development and prognosis of haematological dis...
IPSS, IPSS-R and IPSS-M had no identical prognostic power depending on treatment in myelodysplastic syndromes [0.03%]
IPSS、IPSS-R和IPSS-M的预后价值在不同治疗方式下有所不同
Ghada Abichou,Michael Loschi,Rinzine Sammut et al.
Ghada Abichou et al.
Introduction The Revised International Prognostic Scoring System (IPSS-R) has long been the standard prognostic tool in the management of myelodysplastic syndromes (MDS). Recently, a new clinical-molecular prognostic model, the IPSS-M, was ...
Chronic Graft-Versus-Host Disease: A Review of Current Treatments Beyond Second-Line and Emerging Therapies [0.03%]
慢性移植物抗宿主病：第二线以外的当前治疗和新兴疗法综述
Aseel Saadeh,Dayana Jibrin,Michael Haddadin
Aseel Saadeh
Background: Chronic graft-versus-host disease (cGVHD) remains a major cause of late morbidity and non-relapse mortality following allogeneic hematopoietic cell transplantation. Early identification and intervention are cr...
FLUOROQUINOLONE PROPHYLAXIS FOR FEBRILE NEUTROPENIA IN AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION: OUTCOMES AND RISK FACTORS [0.03%]
自身造血细胞移植中发热性中性粒细胞减少的氟喹诺酮类药物预防：结局和风险因素分析
Fernanda Batista Rosa Pinto,Fernanda Aline Moreira de Oliveira Meucci,Anita Cassoli Cortez et al.
Fernanda Batista Rosa Pinto et al.
Febrile neutropenia (FN) is a complication after autologous hematopoietic cell transplantation (auto-HCT). Although fluoroquinolone (FQ) prophylaxis can reduce FN rates, its use remains debated due to concerns about antimicrobial resistance...
Improving cure rates of B-cell acute lymphoblastic leukemia with chimeric antigen receptor T-cells [0.03%]
用嵌合抗原受体T细胞治疗B细胞急性淋巴细胞白血病以提高治愈率
Yannis K Valtis,Jae H Park
Yannis K Valtis
Chimeric antigen receptor T cell (CAR T) therapy was first approved for the treatment of children and young adults with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL). Since then, two additional CAR T products have been approv...
Post-transplant lymphoproliferative disorder (PTLD) following heart transplantation presenting as a retroperitoneal plasmacytoma - a case report and review of the literature [0.03%]
心脏移植后以腹膜后浆细胞瘤形式出现的移植后淋巴增生性疾病（PTLD）一例及文献复习
Yair Vilian,Adi Sherban,Elad Goldberg et al.
Yair Vilian et al.
Plasma cell neoplasms (PCNs) are a rare type of post-transplant lymphoproliferative disease (PTLD). Extramedullary plasmacytoma is a rare type of PCN, and is infrequently located in the retroperitoneum. According to the current literature, ...
Case Reports
Acta haematologica. 2025 Dec 24:1-21. DOI:10.1159/000550220 2025
A case series of SGLT2i improving hemoglobin in adults with myelodysplastic syndrome [0.03%]
SGLT2抑制剂改善骨髓增生异常综合征成人患者血红蛋白的病例系列分析
Patricia Olar,Stephanie Lee,Michael Fralick
Patricia Olar
Introduction: The objective of our case series was to assess the change in hemoglobin for adults with myelodysplastic syndrome (MDS) started on a sodium glucose cotransporter 2 inhibitor (SGLT2i) for their diabetes, heart...
Case Reports
Acta haematologica. 2025 Dec 24:1-10. DOI:10.1159/000550197 2025
Title: Hans-based cell of origin is not of prognostic significance in DLBCL patients; Retrospective single center study conducted in 326 RCHOP treated patients [0.03%]
基于汉斯分型的起源细胞在DLBCL患者中无预后意义：单中心326例R-CHOP方案治疗患者的回顾性研究
Marianthi Symeonidou,Stergios George Intzes,Konstantinos Zagoridis et al.
Marianthi Symeonidou et al.
Background: Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive lymphoma with dismal outcome after disease progression. Individual risk assessment can stratify patients into different treatment strategies. ...